Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Diabetes Management During Breastfeeding in Women with Type 1 Diabetes

    Research output: Contribution to journalReviewResearchpeer-review

  2. Targeting Inflammation Through a Physical Active Lifestyle and Pharmaceuticals for the Treatment of Type 2 Diabetes

    Research output: Contribution to journalReviewResearchpeer-review

  3. Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

In women with preexisting diabetes and nephropathy or microalbuminuria, it is important to deliver careful preconception counselling to assess the risk for the mother and the foetus, for optimizing glycaemic status and to adjust medical treatment. If serum creatinine is normal in early pregnancy, kidney function is often preserved during pregnancy, but complications such as severe preeclampsia and preterm delivery are still common. Perinatal mortality is now comparable with that in women with diabetes and normal kidney function. Besides strict glycaemic control before and during pregnancy, early and intensive antihypertensive treatment is important to optimize pregnancy outcomes. Methyldopa, labetalol, nifedipine and diltiazem are considered safe, whereas angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers should be stopped before or at confirmation of pregnancy. Supplementation with folic acid in early pregnancy and low-dose aspirin from 10 to 12 weeks reduces the risk of adverse pregnancy outcomes. During breastfeeding, several ACE inhibitors are considered safe.

Original languageEnglish
JournalCurrent Diabetes Reports
Volume16
Issue number2
Pages (from-to)12
ISSN1534-4827
DOIs
Publication statusPublished - Feb 2016

    Research areas

  • Breast Feeding, Diabetic Nephropathies, Female, Humans, Neovascularization, Pathologic, Pre-Eclampsia, Pregnancy, Pregnancy Outcome, Treatment Outcome, Journal Article, Review

ID: 49766296